Pigment Epithelium-Derived Factor as an Anticancer Drug and New Treatment Methods Following the Discovery of Its Receptors: A Patent Perspective
Expert Opinion on Therapeutic Patents - United Kingdom
doi 10.1517/13543776.2011.545347
Full Text
Open PDFAbstract
Available in full text
Date
January 5, 2011
Authors
Publisher
Informa Healthcare